Ampyra
Generic name: Dalfampridine
Drug class:
Miscellaneous central nervous system agents
Usage of Ampyra
Ampyra is a potassium channel blocker.
Ampyra is a prescription medicine used to improve walking in adults with multiple sclerosis (MS).
It is not known if Ampyra is safe or effective in children less than 18 years old.
Ampyra side effects
Get emergency medical help if you have signs of an allergic reaction to Ampyra: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop taking Ampyra and call your doctor right away if you have a seizure.
Call your doctor at once if you have:
Common Ampyra side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Ampyra
You should not use Ampyra if you are allergic to dalfampridine or 4-aminopyridine, or if you have:
Ampyra can cause a seizure, even if you never had one before. Your risk may also be higher if you have kidney problems or are older than 50.
To make sure Ampyra is safe for you, tell your doctor if you have ever had:
Older adults may be more sensitive to the effects of this medication.
It is not known if dalfampridine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
Ask a doctor if it is safe to breastfeed while using this medicine.
Ampyra is not approved for use by anyone younger than 18 years old.
Relate drugs
- Addyi
- Aducanumab
- Aducanumab-avwa
- Aduhelm
- Ampyra
- Bridion
- Dalfampridine
- Daybue
- Dextromethorphan and quinidine
- Droperidol
- Edaravone (Intravenous)
- Edaravone (Oral)
- Edaravone oral/injection
- Ergoloid mesylates
- Exservan
- Fezolinetant
- Flibanserin
- Hydergine
- Inapsine
- Lecanemab injection
- Lecanemab-irmb
- Leqembi
- Leqembi injection
- Memantine
- Namenda
- Namenda XR
- Namenda XR Titration Pack
- Nuedexta
- Omaveloxolone
- Qalsody
- Radicava
- Radicava ORS
- Relyvrio
- Rilutek
- Riluzole
- Skyclarys
- Sodium phenylbutyrate and taurursodiol
- Solriamfetol
- Sugammadex
- Sunosi
- Tiglutik
- Tofersen
- Trofinetide
- Veozah
How to use Ampyra
Usual Adult Dose for Multiple Sclerosis:
Maximum dose: 10 mg orally every 12 hours Comments: -This drug may be taken with or without food. -Tablets should be swallowed whole, and not divided, crushed, chewed, or dissolved. -Patients should not take double or extra doses if a dose is missed. Use: To improve walking in adult patients with multiple sclerosis (MS) demonstrated by an increase in walking speed
Warnings
Ampyra can cause a seizure (convulsions), even if you have never had one before. Taking too much dalfampridine may increase your risk of seizure. Kidney problems may also increase your risk. Your kidney function may need to be tested before you start taking this medicine.
Stop taking Ampyra and call your doctor at once if you a seizure, pain or burning when you urinate, problems with your balance, numbness or tingly feeling, or a relapse of your MS symptoms.
High doses of dalfampridine may increase your risk of seizure. Do not take more than 2 tablets in a 24-hour period. Do not use a tablet that has been broken or crushed. A broken tablet can release too much of the drug at one time.
What other drugs will affect Ampyra
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may interact with dalfampridine, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions